aKLmRNA
compound
aKLmRNA is an emerging therapeutic approach that involves the use of messenger RNA to modulate the expression of the Klotho protein, which is associated with aging and longevity. This approach aims to enhance the body's natural production of Klotho, potentially offering benefits in slowing down the aging process and improving healthspan.
Updated 8/11/2026
aKLmRNA (AKL003)
compound
aKLmRNA (AKL003) is an investigational compound currently undergoing clinical trials. It is designed to modulate the expression of specific proteins through mRNA technology, potentially influencing pathways related to longevity and health optimization. Its exact mechanism and impact on longevity are still under investigation, making it an emerging area of interest.
Updated 8/5/2026
APSMNF 1
compound
APSMNF 1 is a novel compound with limited clinical data, primarily known from a single clinical trial. Its mechanism and potential benefits for longevity or health optimization are not well-documented, making its relevance to these fields uncertain at this time.
Updated 8/5/2026
APSMNF 2
compound
APSMNF 2 is a novel compound with limited available data, primarily known from a single clinical trial. Its mechanism and potential benefits for longevity or health optimization are not well-documented, indicating it is in the early stages of research and development.
Updated 8/5/2026
Colipral
compound
Colipral is a novel compound currently under investigation with limited available data. Its primary mechanism and potential benefits for longevity or health optimization remain largely theoretical at this stage. Further research is needed to establish its efficacy and safety.
Updated 8/11/2026
Eniagor
compound
Eniagor is a novel compound with limited available data, currently undergoing clinical trials. Its primary mechanism and potential benefits for longevity or health optimization are not well-documented, making it an emerging area of interest in the field.
Updated 8/5/2026
N1087
compound
N1087 is a novel compound currently under investigation for its potential health benefits. With limited studies and one clinical trial, its primary mechanism and effects on longevity or health optimization remain largely theoretical. Continued research is needed to determine its efficacy and safety.
Updated 8/5/2026
PIEZO-101
compound
PIEZO-101 is a novel compound currently under investigation, with its primary mechanism likely involving modulation of mechanotransduction pathways. This compound could potentially influence cellular processes related to tissue repair and regeneration, which are crucial for longevity and health optimization.
Updated 8/5/2026